CARGO Other Stockholder Equity from 2010 to 2024

CRGX Stock   15.73  0.09  0.57%   
CARGO Therapeutics, Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity is likely to outpace its year average in 2024. During the period from 2010 to 2024, CARGO Therapeutics, Other Stockholder Equity regression line of annual values had r-squared of  0.37 and arithmetic mean of  18,799,717. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2010-12-31
Previous Quarter
97.5 M
Current Value
102.3 M
Quarterly Volatility
33 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CARGO Therapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CARGO Therapeutics,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 2.4 M or Selling General Administrative of 22 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.47. CARGO financial statements analysis is a perfect complement when working with CARGO Therapeutics, Valuation or Volatility modules.
  
Check out the analysis of CARGO Therapeutics, Correlation against competitors.

Latest CARGO Therapeutics,'s Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of CARGO Therapeutics, Common over the last few years. It is CARGO Therapeutics,'s Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CARGO Therapeutics,'s overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

CARGO Other Stockholder Equity Regression Statistics

Arithmetic Mean18,799,717
Geometric Mean8,972,617
Coefficient Of Variation175.38
Mean Deviation21,624,442
Median5,871,000
Standard Deviation32,970,712
Sample Variance1087.1T
Range96.5M
R-Value0.61
Mean Square Error738.6T
R-Squared0.37
Significance0.02
Slope4,479,112
Total Sum of Squares15219T

CARGO Other Stockholder Equity History

2024102.3 M
202397.5 M
202211.8 M

About CARGO Therapeutics, Financial Statements

CARGO Therapeutics, investors use historical fundamental indicators, such as CARGO Therapeutics,'s Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in CARGO Therapeutics,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity97.5 M102.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CARGO Stock Analysis

When running CARGO Therapeutics,'s price analysis, check to measure CARGO Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CARGO Therapeutics, is operating at the current time. Most of CARGO Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of CARGO Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CARGO Therapeutics,'s price. Additionally, you may evaluate how the addition of CARGO Therapeutics, to your portfolios can decrease your overall portfolio volatility.